Immunomax

Immunomax enhances immune defense against viral and bacterial infections. Immunophar-makologicheskie mechanisms of action of the drug are that Immunomax activates the following parts of the immune system:

• NK cells that, 2-3 hours after exposure to Immunomax, strongly express CD69 activation molecules. The cytolytic activity of NK cells increases by 3 times;
• circulating monocytes after 2-4 hours after activation Immunomax begin to secrete cytokines: interleukin-8, interleukin-1beta and tumor necrosis factor alpha;
• neutrophilic granulocytes are activated by monocytes, the drug has no direct effect on neutrophilic granulocytes. Interleukin-8 secreted by monocytes induces the activation of neutrophilic granulocytes, which clearly manifests itself 24 hours after exposure to Immunomax;
• tissue macrophages, which is manifested in changes in the morphology of these cells, increased production of bactericidal substances, changes in the activity of 5'-nucleotidase;
• the formation of antibodies against foreign antigens, soluble and particulate;

Immunomax enhances protection against infections caused by viruses (human papillomavirus, herpes simplex virus, parvovirus, plague virus carnivorous, etc.) or bacteria (E. coli, salmonella, staphylococcus, chlamydia, mycoplasma, ureaplasma, etc.). This effect of the drug is manifested in adults and newborns with the introduction of Immunomax in various ways: intramuscularly, intravenously, intraperitoneally, per os.